| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/12/2001 | WO2001024772A1 Formulation for menopausal women |
| 04/12/2001 | WO2001024763A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | WO2001024684A2 Methods for treatment of solid tumors and metastasis by gene therapy |
| 04/12/2001 | WO2001024642A1 Nutritional composition for treating inflammatory bowel diseases |
| 04/12/2001 | WO2001024634A1 Active ingredient combinations having insecticidal and acaricidal properties |
| 04/12/2001 | WO2001005420A8 SMALL PEPTIDES AND METHODS FOR DOWNREGULATION OF IgE |
| 04/12/2001 | WO2001005382A8 Synergistic composition comprising daunorubicin derivatives and antimetabolite compounds |
| 04/12/2001 | WO2000077190A3 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
| 04/12/2001 | WO2000066762A3 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus |
| 04/12/2001 | WO2000064425A3 Miotic agents and hypertonic agents containing ophthalmic compositions |
| 04/12/2001 | WO2000057907A3 Multivalent dengue virus vaccine |
| 04/12/2001 | WO2000056333A8 Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance |
| 04/12/2001 | WO2000056304A3 Anti-inflammatory uses of manzamines |
| 04/12/2001 | WO1999051735A3 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy |
| 04/12/2001 | DE19948269A1 New compounds as integrin antagonists useful for treating e.g. cardiovascular disorders, rheumatoid arthritis, kidney failure, stroke, cancer, osteoporosis, psoriasis or infection |
| 04/12/2001 | DE19948129A1 Wirkstoffkombinationen mit insektiziden und akariziden Eigenschaften Drug combinations with insecticidal and acaricidal properties |
| 04/12/2001 | DE19943634A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/12/2001 | CA2645397A1 Formulation for menopausal women |
| 04/12/2001 | CA2608807A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | CA2406882A1 Diagnostic probes and therapeutics targeting upa and upar |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2387703A1 Method for calming human beings using personal care compositions |
| 04/12/2001 | CA2387288A1 Anti-inflammatory pharmaceutical formulations |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386465A1 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386374A1 Methods for treatment of solid tumors and metastasis by gene therapy |
| 04/12/2001 | CA2386360A1 Active ingredient combinations having insecticidal and acaricidal properties |
| 04/12/2001 | CA2386252A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386236A1 Human inwardly rectifying potassium channel subunit |
| 04/12/2001 | CA2386228A1 Stabilized liquid pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) polypeptides |
| 04/12/2001 | CA2386218A1 Triazine kinase inhibitors |
| 04/12/2001 | CA2386089A1 Diagnostic and therapeutic epitope and transgenic plant |
| 04/12/2001 | CA2386030A1 Integrin receptor antagonists |
| 04/12/2001 | CA2385966A1 Pharmaceutical compositions of fibrinolytic agent |
| 04/12/2001 | CA2385930A1 Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385696A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 04/12/2001 | CA2385528A1 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | CA2385313A1 Foams and compositions containing these foams |
| 04/12/2001 | CA2384696A1 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/11/2001 | EP1090990A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090925A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090644A2 Combination effective for the treatment of impotence comprising a potassium-channel-opener and a cGMP elevator |
| 04/11/2001 | EP1090639A2 Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator |
| 04/11/2001 | EP1090637A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/11/2001 | EP1090635A2 Use of ferulic acid for treating hypertension |
| 04/11/2001 | EP1090118A2 Human signal peptide-containing proteins |
| 04/11/2001 | EP1090116A2 Transgenic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 04/11/2001 | EP1090104A1 Methods of expanding and selecting disease associated t-cells |
| 04/11/2001 | EP1089794A2 Methods for inhibiting tef-3 activity |
| 04/11/2001 | EP1089766A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 04/11/2001 | EP1089761A2 Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies |
| 04/11/2001 | EP1089751A1 Adjuvant therapy |
| 04/11/2001 | EP1089750A1 Compositions and methods for inhibiting bone resorption |
| 04/11/2001 | EP1089749A1 Novel therapeutic agents for membrane transporters |
| 04/11/2001 | EP1089741A1 Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv |
| 04/11/2001 | EP1089736A2 Method and compositions for the treatment or amelioration of female sexual dysfunction |
| 04/11/2001 | EP1089732A1 Compositions and methods for treating elevated blood cholesterol |
| 04/11/2001 | EP1089728A1 Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
| 04/11/2001 | EP1089723A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 04/11/2001 | EP1089713A1 Temperature-sensitive liposomal formulation |
| 04/11/2001 | EP1089709A1 Icecream-type pharmaceutical formulation and process for preparing the same |
| 04/11/2001 | EP0963203A4 Mammalian tolloid-like gene and protein |
| 04/11/2001 | CN1291228A Enzyme catalyzed therapeutic agents |
| 04/11/2001 | CN1291198A Three-dimesional structures and models of Fc receptors and use thereof |
| 04/11/2001 | CN1291104A A pharmaceutical preparation comprising an angiotension II2 type receptor agonist, and use thereof |
| 04/11/2001 | CN1291096A Use of inhibitors for treatment of disorders related to RTK hyperfunction |
| 04/11/2001 | CN1291092A pharmaceutical Combinations containing tramadol |
| 04/10/2001 | US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia |
| 04/10/2001 | US6214863 Synergistic therapy for breast cancer consisting of taxol or taxotere and derivatives, with alkylating agent such as cyclophosphamide and anthracycline antibiotic (daunorubicin or doxorubicin); avoiding/ delaying multi-drug resistance |
| 04/10/2001 | US6214860 Anticancer agents |
| 04/10/2001 | US6214854 Administering adrenoceptor, or antagonist thereof; cardiovascular disorders |
| 04/10/2001 | US6214852 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 04/10/2001 | US6214850 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 04/10/2001 | US6214848 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action for prophylaxis and treatment of diabetes; depressing diabetic hyperglycemia |
| 04/10/2001 | US6214810 Methods of treating or preventing cardiac arrhythmia |
| 04/10/2001 | US6214809 Methods of treating or preventing cardiac arrhythmia |
| 04/10/2001 | US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections |
| 04/10/2001 | US6214580 Nucleotide sequences coding binding protein associated with apoptosis; for detecting modulators of apoptosis; for treating cancers, sepsis, cachexia, autoimmune and viral diseases, inflammation, nervous system and liver disorders |
| 04/10/2001 | US6214562 Transcriptionally regualted G protein-coupled receptor |
| 04/10/2001 | US6214543 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 04/10/2001 | US6214536 Method of detecting lung disease |
| 04/10/2001 | US6214535 Diagnosing cardiovascular disorders; obtain heart muscle tissue, detect hepatitis virus in tissues |
| 04/10/2001 | US6214387 Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
| 04/10/2001 | US6214373 Nutritional composition for treating inflammatory bowel diseases |
| 04/10/2001 | US6214348 Administering to the mammal a polypeptide comprising seq id no:2 in an amount sufficient to induce an immunological response to produce antibodies to seq id no:2 |
| 04/10/2001 | US6214346 Bactericides |
| 04/10/2001 | US6214318 Comprising mineral oils, vegetable oils, silicone oils or synthetic oils; thickening agents such as waxes to thicken oils to non-flowable state; optionally adjuvants, drugs and emulsifiers and a liquefied propellant; cooling effect |
| 04/10/2001 | US6214008 Biodegradable osteosynthesis implant |
| 04/10/2001 | CA2059263C Composition comprising the (-) enantiomer of cis-4-amino-1-(2-hydromethyl-1,3-oxathiolan-5-yl)-(1h)-pyrimidine-2-one or an enriched composition thereof, and its uses as a pharmaceutical agent |
| 04/07/2001 | CA2320400A1 Gene necessary for striatal function and uses thereof, and compounds for modulating same |
| 04/06/2001 | CA2322560A1 Corticoid therapy |